跳至主要内容
临床试验/CTIS2022-501519-15-00
CTIS2022-501519-15-00招募中1 期

Optimisation of lymph node fine needle aspiration to study pneumococcal vaccine-induced immunity

eiden University Medical Center0 个研究点目标入组 5 人开始时间: 2022年11月14日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)
性别
All

入选标准

  • Participants between the ages of 20 and 40 years old, Participants should be generally healthy and without substantial comorbidities, including all auto-immune diseases that are being actively treated with immunosuppressive therapy. Patients with chronic diseases that do not require immunosuppressive therapy and are stable, defined as not requiring change of therapy or hospitalization in the six weeks preceding study enrolment, might be eligible for this study.

排除标准

  • Subject has a BMI > 30, Breastfeeding during the course of the study, Documented pneumococcal vaccination and/or infection, Documented HIV infection, Documented primary immune disorder or primary coagulopathy, Use of immunosuppressive medication or anticoagulants, Known hypersensitivity to any of the vaccine components, Recent (i.e. <4 weeks before inclusion) surgery in axillar area or major surgery elsewhere, Fever at time of inclusion, Pregnancy at time of inclusion

研究者

发起方
eiden University Medical Center

相似试验